| Astrocytoma, IDH-Mutant studied in …STUDIED_INderived25 of 25show fewer |
|---|
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ALIAS · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03528642Phase 1 · active not recruiting Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma · condition mapped ONTOLOGY_EXACT · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07703436Phase 2 · not yet recruiting Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease · condition mapped ONTOLOGY_EXACT · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831369Phase 2 · recruiting VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma · condition mapped ONTOLOGY_EXACT · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860594Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma · condition mapped CURATED_BROADER · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07215910Phase 3 · recruiting Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer · condition mapped ONTOLOGY_EXACT · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145115Phase 2 · active not recruiting A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden · condition mapped ONTOLOGY_EXACT · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05303519Phase 3 · recruiting SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) · condition mapped ONTOLOGY_EXACT · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07544992Phase 1 · recruiting Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas · condition mapped CURATED_BROADER · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07712757Phase 3 · not yet recruiting Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma · condition mapped ONTOLOGY_EXACT · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06815029Phase 1 · recruiting Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma · condition mapped CURATED_BROADER · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07673666completed GliomaAI-Astro23: MRI-Based Detection of IDH Mutant Astrocytoma (Grade 2 and 3) · condition mapped ONTOLOGY_EXACT · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07673679completed GliomaAI-Astro4: MRI-Based Detection of IDH Mutant Astrocytoma Grade 4 · condition mapped ONTOLOGY_EXACT · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07468136Phase 1/Phase 2 · recruiting Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas · condition mapped ONTOLOGY_EXACT · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05190172NA · recruiting PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas · condition mapped ALIAS · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625047Phase 4 · completed Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy · condition mapped ONTOLOGY_EXACT · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05565521Phase 2 · active not recruiting UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly · condition mapped ALIAS · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07301268Phase 2 · recruiting GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma · condition mapped CURATED_BROADER · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05789394Phase 1 · recruiting Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy · condition mapped CURATED_BROADER · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05375318completed BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels · condition mapped ALIAS · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06896110Phase 1 · enrolling by invitation Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma · condition mapped ONTOLOGY_EXACT · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05879367Phase 1 · recruiting Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma · condition mapped ONTOLOGY_EXACT · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06623565NA · recruiting Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques · condition mapped ONTOLOGY_EXACT · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03434262Phase 1 · completed SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors · condition mapped ALIAS · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06118723recruiting The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) · condition mapped ALIAS · 25 trials mapped (20 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |